ATE226592T1 - Peptide, die metallproteinasen und die tnf- freisetzung hemmen, und ihre therapeutische verwendung - Google Patents
Peptide, die metallproteinasen und die tnf- freisetzung hemmen, und ihre therapeutische verwendungInfo
- Publication number
- ATE226592T1 ATE226592T1 AT96915089T AT96915089T ATE226592T1 AT E226592 T1 ATE226592 T1 AT E226592T1 AT 96915089 T AT96915089 T AT 96915089T AT 96915089 T AT96915089 T AT 96915089T AT E226592 T1 ATE226592 T1 AT E226592T1
- Authority
- AT
- Austria
- Prior art keywords
- metalproteinases
- therapeutic use
- tnf release
- peptides inhibiting
- peptides
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 230000002401 inhibitory effect Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06052—Val-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9509434.8A GB9509434D0 (en) | 1995-05-10 | 1995-05-10 | Compounds |
| GBGB9525643.4A GB9525643D0 (en) | 1995-12-15 | 1995-12-15 | Compounds |
| GBGB9607218.6A GB9607218D0 (en) | 1996-04-04 | 1996-04-04 | Compounds |
| PCT/GB1996/001138 WO1996035714A1 (en) | 1995-05-10 | 1996-05-10 | Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226592T1 true ATE226592T1 (de) | 2002-11-15 |
Family
ID=27267715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96915089T ATE226592T1 (de) | 1995-05-10 | 1996-05-10 | Peptide, die metallproteinasen und die tnf- freisetzung hemmen, und ihre therapeutische verwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6110896A (de) |
| EP (1) | EP0826000B1 (de) |
| JP (1) | JPH11504646A (de) |
| AT (1) | ATE226592T1 (de) |
| AU (1) | AU701279B2 (de) |
| CA (1) | CA2217857A1 (de) |
| DE (1) | DE69624477T2 (de) |
| ES (1) | ES2184861T3 (de) |
| WO (1) | WO1996035714A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406901B1 (en) | 1995-06-08 | 2002-06-18 | Immunex Corporation | TNF-a converting enzyme |
| GB9607120D0 (en) * | 1996-04-04 | 1996-06-12 | Chiroscience Ltd | Compounds |
| US6953788B1 (en) | 1996-09-19 | 2005-10-11 | Aventis Pharmaceuticals Inc. | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| MXPA99001974A (es) * | 1996-12-09 | 2002-03-27 | Warner Lambert Co | Metodo para tratar y prevenir fallas cardiacas y dilatacion ventricular. |
| US6172057B1 (en) | 1997-02-27 | 2001-01-09 | American Cyanamid Company | N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| AU748998B2 (en) * | 1997-02-27 | 2002-06-13 | Wyeth Holdings Corporation | N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| CA2317604C (en) | 1998-01-09 | 2004-12-21 | Pfizer Inc. | Matrix metalloprotease inhibitors |
| DE69934094T2 (de) * | 1998-01-30 | 2007-06-06 | Darwin Discovery Ltd., Slough | N-hydroxyformamid-derivate |
| IL137147A0 (en) * | 1998-02-06 | 2001-07-24 | Darwin Discovery Ltd | Hydroxamic and carboxylic acid derivatives |
| US6680338B2 (en) | 1998-02-06 | 2004-01-20 | Darwin Discovery Ltd. | Hydroxamic and carboxylic acid derivatives |
| GB9823334D0 (en) * | 1998-10-23 | 1998-12-23 | Darwin Discovery Ltd | Enzyme coupling |
| CN1377276A (zh) * | 1999-08-09 | 2002-10-30 | 特里帕普股份公司 | 含有三肽的药用组合物 |
| CA2408408C (en) | 2000-05-12 | 2013-07-09 | Genzyme Corporation | Modulators of tnf- alpha signaling |
| US20030228320A1 (en) * | 2000-08-18 | 2003-12-11 | Ashdown Martin Leonard | Retroviral immunotherapy |
| US6593455B2 (en) | 2001-08-24 | 2003-07-15 | Tripep Ab | Tripeptide amides that block viral infectivity and methods of use thereof |
| EP1436317A1 (de) | 2001-09-19 | 2004-07-14 | Tripep Ab | Moleküle, die die virale infektivität hemmen, und verfahren zu deren anwendung |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| EP2576554A1 (de) | 2010-05-31 | 2013-04-10 | Syngenta Participations AG | 1, 8 -diazaspiro [4.5]decan- 2, 4 -dion-derivate als pestizide |
| CN103003239A (zh) | 2010-05-31 | 2013-03-27 | 先正达参股股份有限公司 | 基于螺杂环吡咯烷衍生物的杀虫剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8311286D0 (en) * | 1983-04-26 | 1983-06-02 | Searle & Co | Carboxyalkyl peptide derivatives |
| NZ223037A (en) * | 1986-12-24 | 1991-04-26 | Beecham Group Plc | Thiol-carboxylic acid derivatives and pharmaceutical compositions thereof |
| DE3889726T2 (de) * | 1987-03-17 | 1994-10-13 | Res Corp Technologies Inc | Synthetische inhibitoren von säugetier-collagenase. |
| DE4311021A1 (de) * | 1993-03-31 | 1994-10-27 | Diagnostikforschung Inst | Bifunktionelle Chelatbildner, deren Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende radiopharmazeutische Mittel |
| FI960803L (fi) * | 1993-08-23 | 1996-04-22 | Immunex Corp | TNF-alfa-sekreetion inhibiittoreita |
| GB9323165D0 (en) * | 1993-11-10 | 1994-01-05 | Chiros Ltd | Compounds |
| JP3787605B2 (ja) * | 1994-10-05 | 2006-06-21 | ダーウィン・ディスカバリー・リミテッド | ペプチジル化合物および金属プロテアーゼのインヒビターとしてのその治療的使用 |
-
1996
- 1996-05-10 WO PCT/GB1996/001138 patent/WO1996035714A1/en not_active Ceased
- 1996-05-10 AU AU56980/96A patent/AU701279B2/en not_active Ceased
- 1996-05-10 AT AT96915089T patent/ATE226592T1/de not_active IP Right Cessation
- 1996-05-10 CA CA002217857A patent/CA2217857A1/en not_active Abandoned
- 1996-05-10 ES ES96915089T patent/ES2184861T3/es not_active Expired - Lifetime
- 1996-05-10 US US08/644,797 patent/US6110896A/en not_active Expired - Fee Related
- 1996-05-10 JP JP8533891A patent/JPH11504646A/ja not_active Ceased
- 1996-05-10 DE DE69624477T patent/DE69624477T2/de not_active Expired - Fee Related
- 1996-05-10 EP EP96915089A patent/EP0826000B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU701279B2 (en) | 1999-01-21 |
| JPH11504646A (ja) | 1999-04-27 |
| AU5698096A (en) | 1996-11-29 |
| EP0826000A1 (de) | 1998-03-04 |
| ES2184861T3 (es) | 2003-04-16 |
| CA2217857A1 (en) | 1996-11-14 |
| DE69624477D1 (de) | 2002-11-28 |
| DE69624477T2 (de) | 2003-06-26 |
| WO1996035714A1 (en) | 1996-11-14 |
| EP0826000B1 (de) | 2002-10-23 |
| US6110896A (en) | 2000-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69624477D1 (de) | Peptide, die metallproteinasen und die tnf-freisetzung hemmen, und ihre therapeutische verwendung | |
| DE69604860D1 (de) | Orthopädisches Befestigungsmittel | |
| EG23871A (en) | Protein kinase c inhibitor | |
| DK0737457T3 (da) | Ostomikobling | |
| IL122782A (en) | Triazole salts and pharmaceutical compositions containing the same and methods for evaluating the susceptibility of a cancer to growth inhibition utilizing the same | |
| EP0611775A3 (de) | Krebshemmende Pentapeptid-Amide. | |
| FI980038L (fi) | Tuumorinekroositekijän alfa inhibiittoreita | |
| DE69625506D1 (de) | Schwefelsubstituierte peptide als inhibitoren für metalloproteinasen und der tnf-freisetzung | |
| DE69632758D1 (de) | Ostomiekupplung | |
| DE69627483D1 (de) | Peptidartige stoffe, die metalloproteinasen und die tnf-freisetzung hemmen, und ihre therapeutische verwendung | |
| MX9803662A (es) | Oligopeptidos novedosos, preparacion y uso de estos. | |
| KR960016814A (ko) | 쌀 공급 장치 | |
| KR960026792U (ko) | 풍구 | |
| EP0815199A4 (de) | Menschliche deoxycytidinkinase | |
| KR970039033U (ko) | 풍구 옥토막이 장치 | |
| KR960033308U (ko) | 신발끈 고리쇠 자동체결기의 고리쇠 공급장치 | |
| FI973071A7 (fi) | Syöttölaite | |
| KR960028010U (ko) | 돼지 사료 급식기 | |
| KR970004672U (ko) | 압정 | |
| KR960028540U (ko) | 압정 | |
| KR970016594U (ko) | 압정 | |
| KR950002559U (ko) | 이앙기 장착용 담수직파기 | |
| KR960035944U (ko) | 양돈용 사료 자동급이기 | |
| KR970000055U (ko) | 양돈용 먹이통 | |
| IT238774Y1 (it) | Chiusura per monili |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |